ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.535
0.40%
US Dollar vs AUD
1.49566
-0.07%
Bitcoin
67,049.11
2.77%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. InVivo Therapeutics Holdings Corporation (NVIV)

  7. InVivo Therapeutics Holdings Corporation (NVIV) News

NVIV

InVivo Therapeutics (NVIV)

InVivo Therapeutics Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVIV
DateTimeSourceHeadlineSymbolCompany
22/03/202405:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
15/02/202406:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202412:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/02/202406:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/02/202405:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202404:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/02/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/12/202300:35Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/12/202300:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/12/202308:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/12/202302:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202308:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/09/202306:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
10/08/202306:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
13/05/202306:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
26/04/202307:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
10/03/202301:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
10/03/202300:55Business WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/03/202308:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
15/02/202305:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202222:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202209:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
19/11/202208:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202222:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:NVIV

Your Recent History

ASX
SUN
Suncorp
NASDAQ
TSLA
Tesla
NYSE
NKE
Nike
ASX
WES
Wesfarmers
ASX
XTO
S&P ASX 100
PM
XAUUSD
Gold vs US Dollar
ASX
MQG
Macquarie
NASDAQ
AMZN
Amazon.com
FX
GBPAUD
Sterling vs AUD
ASX
RIO
Rio Tinto
ASX
CSL
CSL
FX
AUDUSD
AUD vs US Dollar
ASX
BHP
BHP
ASX
FMG
Fortescue
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved